| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 0.500 | None | 0.941 | 1 | 1 | 1993 | 2020 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2006 | 2019 | ||||||||
|
diacylglycerol kinase eta | 0.678 | 0.346 | 2.6E-02 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.991 | 1 | 1 | 1988 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 1995 | 2019 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
phenotype | 0.500 | None | 1.000 | 1 | 11 | 2002 | 2012 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
group | 0.500 | None | 0.981 | 1 | 1 | 1996 | 2020 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.906 | 1 | 1 | 1995 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
claudin 14 | 0.705 | 0.462 | 1.1E-04 |
|
disease | 0.500 | None | 1.000 | 1 | 3 | 2009 | 2018 | ||||||||
|
bromodomain containing 1 | 0.644 | 0.654 | 1.00 |
|
disease | 0.500 | None | 0.800 | 1 | 1 | 2006 | 2019 | ||||||||
|
follicle stimulating hormone receptor | 0.539 | 0.654 | 1.4E-11 |
|
disease | 0.500 | None | 0.897 | 1 | 3 | 1997 | 2020 | ||||||||
|
nuclear receptor subfamily 5 group A member 2 | 0.563 | 0.731 | 0.24 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
contactin associated protein 2 | 0.530 | 0.846 | 2.9E-09 |
|
disease | 0.500 | None | 0.975 | 1 | 1 | 2008 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
group | 0.500 | None | 0.948 | 1 | 1 | 2004 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.500 | None | 0.968 | 1 | 1 | 2004 | 2019 | ||||||||
|
TOX high mobility group box family member 3 | 0.636 | 0.538 | 1.00 |
|
disease | 0.500 | None | 0.942 | 1 | 2 | 2007 | 2019 | ||||||||
|
bridging integrator 1 | 0.550 | 0.692 | 0.78 |
|
disease | 0.500 | None | 0.980 | 1 | 1 | 2011 | 2020 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.500 | None | 0.960 | 1 | 1 | 2009 | 2018 | |||||||||
|
complement factor H related 1 | 0.588 | 0.615 | 2.6E-08 |
|
disease | 0.500 | moderate | 1.000 | 1 | 3 | 2006 | 2017 | ||||||||
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.948 | 1 | 1 | 2002 | 2020 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.500 | None | 0.955 | 1 | 1 | 1980 | 2020 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 1.000 | 1 | 2 | 2004 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.946 | 1 | 5 | 1988 | 2020 |